Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Although recent findings suggest some patients with HER2-negative breast cancer would benefit from therapies directed against overexpression of the protein, two leading oncologists do not see an immediate impact on clinical practice as further validation is needed.

Leading Oncologists Analyze Impact of New HER2 Research on Clinical Practice

Constance D. Lehman, MD, PhD,  Vice Chair, Radiology Department, University of Washington School of Medicine, Medical Director, Imaging, Seattle Cancer Care Alliance, discusses the use of breast MRI.

Dr. Lehman Discusses the Use of Breast MRI

Conclusion and Final Thoughts on Managing Breast Cancer

Personalized Medicine in Triple-Negative Breast Cancer

Case Study: Metastatic Triple-Negative Breast Cancer

Surgical Removal of Primary Tumors in Stage IV MBC

Managing Bone Health in Metastatic Breast Cancer

Case Study: Treating HR+ and HER2- Breast Cancer

Paclitaxel With Pertuzumab Plus Trastuzumab in MBC

Case Study: Treating HER2-Positive MBC, Part II

Case Study: Treating HER2-Positive MBC, Part I

Treatment With Eribulin in Metastatic Breast Cancer

MA.31 Trial: Taxane With Lapatinib or Trastuzumab

CLEOPATRA Trial: Frontline Pertuzumab for HER2+ MBC

Frontline T-DM1 in HER2+ Metastatic Breast Cancer

EMILIA Trial: T-DM1 in Metastatic Breast Cancer

Management of mTOR Inhibitor Side Effects in Breast Cancer

BOLERO-2 Trial: Everolimus in Metastatic Breast Cancer

Combination of Anastrozole and Fulvestrant in MBC

Introduction and Exploration of Fulvestrant in Breast Cancer

HER2+ Breast Cancer

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Breast Cancer

ELI-22-OSD1261 - /clinical/colorectal-cancer

Breast Cancer | Specialty